Cargando…

Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

BACKGROUND: In contrast to olanzapine, ziprasidone has been reported to cause minimal or no weight gain. This study aimed to compare the effects of ziprasidone and olanzapine on weight, body composition, appetite, resting energy expenditure, substrate oxidation, and metabolic parameters in adults wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Subin, Yi, Ki Kyoung, Kim, Min-Seon, Hong, Jin Pyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729530/ https://www.ncbi.nlm.nih.gov/pubmed/23866300 http://dx.doi.org/10.1186/1744-9081-9-27

Ejemplares similares

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
por: Gobbi, Gabriella, et al.
Publicado: (2014)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: A prospective open label observational study
por: Choure, Balwant Kisanrao, et al.
Publicado: (2014)

OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN LABEL COMPARATIVE CLINICAL TRIAL FROM NORTH INDIA
por: Avasthi, Ajit, et al.
Publicado: (2001)

Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Effects of haloperidol, olanzapine, ziprasidone, and PHA‐543613 on spatial learning and memory in the Morris water maze test in naïve and MK‐801‐treated mice
por: Ning, Houxu, et al.
Publicado: (2017)

The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study
por: Wu, Yaxue, et al.
Publicado: (2023)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
por: Kumar, Subodh, et al.
Publicado: (2014)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Evidence review and clinical guidance for the use of ziprasidone in Canada
por: Gardner, David M, et al.
Publicado: (2013)

Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
por: Wani, Rayees Ahmad, et al.
Publicado: (2015)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
Publicado: (2015)

Nonisothermal Kinetics Analysis of the Dehydration of Ziprasidone Hydrochloride Monohydrate by Thermogravimetry
por: Ravikiran, A., et al.
Publicado: (2013)

Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone
por: Khan, Afshan A, et al.
Publicado: (2010)

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine
por: Bartolommei, Natalia, et al.
Publicado: (2014)

Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

Efficacy of Ziprasidone in Controlling Agitation during Post-Traumatic Amnesia
por: Noé, Enrique, et al.
Publicado: (2007)

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
por: Schoretsanitis, Georgios, et al.
Publicado: (2022)

Analgesic Effects of Oxycodone in Combination With Risperidone or Ziprasidone: Results From a Pilot Randomized Controlled Trial in Healthy Volunteers
por: Nagpal, Ameet S., et al.
Publicado: (2022)

Ziprasidone and its Association with Sudden Cardiac Death - A Case Report
por: Sidana, Ajeet, et al.
Publicado: (2004)

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
por: Younce, John R., et al.
Publicado: (2019)

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female
por: Wilson, Alphonso, et al.
Publicado: (2020)

Restless legs syndrome following the use of ziprasidone: a case report
por: Zhu, Cuizhen, et al.
Publicado: (2020)

Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
por: Ganguli, Rohan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hhrfp97qemf59u087295rkentr